Bevacizumab Slows Progression Of Metastatic Breast Cancer But Has No Impact On Surviv
The cancer drug bevacizumab (AvastinĀ®) offers only a modest benefit in delaying disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers...